Previous close | 1.5670 |
Open | 1.5350 |
Bid | 1.5300 x 0 |
Ask | 1.6200 x 0 |
Day's range | 1.5260 - 1.6200 |
52-week range | 1.1000 - 7.1340 |
Volume | |
Avg. volume | 15,581,504 |
Market cap | 21.026M |
Beta (5Y monthly) | 3.03 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Chimeric Bait Receptors for Combatting Brain Cancers and Neurodegenerative Diseases Can Be Delivered via Programmed Microglial Cells LONDON, UK / ACCESSWIRE / February 16, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the clinical stage biopharmaceutical ...
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the Company has received a notice from the U.S.